In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.
In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.
Ann Intern Med. 2020 Feb 18;172(4):JC18
Authors: Ai Ng SY, Zhu D, Herrington WG
PMID: 32066151 [PubMed - in process]
Source: Annals of Internal Medicine - Category: Internal Medicine Authors: Ai Ng SY, Zhu D, Herrington WG Tags: Ann Intern Med Source Type: research